Strong Quarterly Shipments and Revenue Growth
Q4 shipments of 365,000 tons, up 11% year-over-year; Q4 revenue of $2.2 billion, up 28% year-over-year driven by higher shipments and higher revenue per ton (including higher metal prices).
Significant Improvement in Profitability (Quarter)
Q4 net income of $113 million versus a net loss of $47 million in Q4 2024. Adjusted EBITDA for Q4 was $280 million, up 124% year-over-year; excluding a $67 million positive noncash metal price lag impact, adjusted EBITDA was $213 million (up 113% vs. $100 million in Q4 2024).
Full Year Revenue and EBITDA Gains
FY2025 revenue of $8.4 billion, up 15% versus 2024. FY adjusted EBITDA was $846 million, up 36% year-over-year; excluding a $126 million positive metal price lag impact, adjusted EBITDA was $720 million (up from $575 million in 2024, ~25% increase) — the company's second-best year ever on that basis.
Improved Cash Generation and Capital Returns
Q4 free cash flow of $110 million and FY free cash flow of $178 million (well ahead of 2024). Returned $115 million to shareholders in 2025 via repurchases (8.9 million shares), including $40 million (2.4 million shares) in Q4; ~$106 million remaining on repurchase authorization to be funded by free cash flow.
Segment-Level Records and Strong PARP Performance
PARP delivered a quarterly record adjusted EBITDA of $136 million in Q4, up 143% year-over-year; packaging shipments increased 15% in Q4 and muscle shoals operational improvement materially helped results. A&T Q4 adjusted EBITDA was $83 million, up 43% year-over-year with TID shipments up 41%.
Balance Sheet Strength and Leverage Improvement
Net debt of $1.8 billion at year-end 2025 (translation-driven increase ~ $50M); leverage reduced to 2.5x (at the upper end of target range). Liquidity increased ~ $140 million year-over-year to $866 million; no bond maturities until 2028 and no outstanding ABL borrowings.
Clear 2026 Guidance and 2028 Targets
2026 guidance: adjusted EBITDA excluding metal price lag $780M–$820M and free cash flow in excess of $200M. Reiterated 2028 targets of adjusted EBITDA (ex-lag) $900M and free cash flow $300M, with Vision 2028 program launched to drive operational efficiencies and cost reduction.
Safety and Operational Improvements
Recordable case rate improved to 1.9 in 2025 (better than industry average) and operational recoveries (e.g., Muscle Shoals and Valais) supported quarterly volume and profitability gains.